Analysts have raised their price target for Maximus from $105 to $110, citing a slight improvement in projected profit margins. This comes despite moderating revenue growth expectations and updated financial modeling.
What's in the News
- Completed repurchase of 8,967,470 shares, representing 15.01 percent, for $678.58 million under the buyback announced in 2020. This includes 1,721,139 shares repurchased between July and September 2025 for $150.84 million (Company Filing).
- Issued fiscal 2026 earnings guidance, expecting revenue between $5.225 billion and $5.425 billion (Company Announcement).
- Awarded a new Joint Cyber Command & Control (JCC2) Readiness contract by the U.S. Air Force with a potential value of $86 million to lead engineering analysis and technology enhancements (Company Announcement).
- Secured a $31 million contract with Massachusetts Health Connector to provide enrollment and premium billing services, including launching a redesigned member portal (Company Announcement).
- Selected by Pennsylvania's Department of Human Services for a five-year, $62 million contract to administer the Enrollment Assistance Program. The program now supports CHIP recipients with new digital engagement tools (Company Announcement).
Valuation Changes
- Consensus Analyst Price Target has risen slightly from $105 to $110.
- The discount rate increased moderately and is now at 7.73 percent compared to 7.06 percent previously.
- Revenue growth expectation has fallen, updated from 3.89 percent to 2.81 percent.
- Net profit margin ticked up marginally and is now at 8.04 percent versus 7.99 percent prior.
- Future P/E has moved higher, rising from 11.9x to 13.9x.
Have other thoughts on Maximus?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.